Table 2.
The median and mean scores of patients with and without 6-week MACE by each stratification tools
| Stratification tool | Total population (n = 274) | 6-week MACE (n = 68) | No 6-week MACE (n = 206) | P-value |
|---|---|---|---|---|
| HEART score (0–10) | Mean: 3.40 | Mean: 6.26 | Mean: 2.46 | 0.000 |
| Median: 3 | Median: 7 | Median: 2 | ||
| IQR: (2–4) | IQR: (5–8) | IQR: (1–3) | ||
| HET score (0–6) | Mean: 1.32 | Mean: 3.54 | Mean: 0.59 | 0.000 |
| Median: 1 | Median: 4 | Median: 0 | ||
| IQR: (0–2) | IQR: (2–5) | IQR: (0–1) | ||
| TIMI score (0–7) | Mean: 1.99 | Mean: 3.79 | Mean: 1.40 | 0.000 |
| Median: 2 | Median: 4 | Median: 1 | ||
| IQR: (1–3) | IQR: (3–5) | IQR: (0–2) | ||
| EDACS-ADP b score (0–1) | Mean: 0.46 | Mean: 0.91 | Mean: 0.31 | 0.000 |
| Median: 0 | Median: 1 | Median: 0 | ||
| IQR: (0–1) | IQR: (1–1) | IQR: (0–1) | ||
| GRACE a score (1-384) | Mean: 107.37* | Mean: 131.48* | Mean: 92.56* | 0.000 |
| Median: 104 | Median: 127 | Median: 87 | ||
| IQR: (81–128) | IQR: (105–153) | IQR: (74–111) |
a GRACE score was calculated for 163 patients with available creatinine levels
b EDACS-ADP scores were binarized for analysis: 1 = High Risk, 0 = Low Risk. 91.2% of patients in the MACE group and 31% of those without MACE were classified as high-risk by the EDACS-ADP